in order to treat inflammatory bowel disease there is the need of multidisciplinary team: doctors, specialist IBD nurse,dietitians,counselors if available.Biological therapies for both CD and UC will be used selectively based on personalized benefit/risk assessment and will be optimized through the course of the treatment.Choice of the therapy will depend on individual patient profiles,determined through reliable bio markers and tissue signatures. Drug monitoring will be part of treatment optimization.egységes, osztatlanáltalános orvosango
Inflammatory bowel disease (IBD); a chronic progressive illness characterised by dysregulation of th...
AbstractBackground and aimsClinical management of inflammatory bowel diseases (IBD), new treatment m...
A pluridisciplinary approach that integrates medical therapy with surgery and other aspects of patie...
Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) characterized...
IBD is an idiopathic, chronic inflammation resulting from UC or CD. During the last decades biologic...
Inflammatory bowel disease (IBD) is a chronic inflammatory disease affecting the gastrointestinal tr...
Inflammatory bowel disease is a lifelong disease, which is incurable with medical treatment, however...
Biological therapy revolutionized the treatment of inflammatory bowel disease (IBD) during the last ...
IBD is a multifactorial disorder of unknown etiology. The treatment of IBD in any given patient may ...
Crohn’s disease (CD) and ulcerative colitis (UC) are intestinal disorders that comprise the inflamma...
Inflammatory bowel disease (IBD) is an idiopathic chronic disease. According to the latest data, abo...
Inflammatory bowel disease (IBD) represents a group of chronic disorders of the gastrointestinal tra...
Inflammatory bowel diseases (IBD) are idiopathic, chronic intestinal inflammatory diseases. IBD path...
With the expanding armamentarium in IBD the current treatment targets can be reached. By optimally u...
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have moved beyond ...
Inflammatory bowel disease (IBD); a chronic progressive illness characterised by dysregulation of th...
AbstractBackground and aimsClinical management of inflammatory bowel diseases (IBD), new treatment m...
A pluridisciplinary approach that integrates medical therapy with surgery and other aspects of patie...
Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) characterized...
IBD is an idiopathic, chronic inflammation resulting from UC or CD. During the last decades biologic...
Inflammatory bowel disease (IBD) is a chronic inflammatory disease affecting the gastrointestinal tr...
Inflammatory bowel disease is a lifelong disease, which is incurable with medical treatment, however...
Biological therapy revolutionized the treatment of inflammatory bowel disease (IBD) during the last ...
IBD is a multifactorial disorder of unknown etiology. The treatment of IBD in any given patient may ...
Crohn’s disease (CD) and ulcerative colitis (UC) are intestinal disorders that comprise the inflamma...
Inflammatory bowel disease (IBD) is an idiopathic chronic disease. According to the latest data, abo...
Inflammatory bowel disease (IBD) represents a group of chronic disorders of the gastrointestinal tra...
Inflammatory bowel diseases (IBD) are idiopathic, chronic intestinal inflammatory diseases. IBD path...
With the expanding armamentarium in IBD the current treatment targets can be reached. By optimally u...
Proposed treatment targets for the management of inflammatory bowel disease (IBD) have moved beyond ...
Inflammatory bowel disease (IBD); a chronic progressive illness characterised by dysregulation of th...
AbstractBackground and aimsClinical management of inflammatory bowel diseases (IBD), new treatment m...
A pluridisciplinary approach that integrates medical therapy with surgery and other aspects of patie...
Add to ORKG